Literature DB >> 9868806

In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid.

W Stummer1, S Stocker, A Novotny, A Heimann, O Sauer, O Kempski, N Plesnila, J Wietzorrek, H J Reulen.   

Abstract

Several malignant tissues synthesize endogenous porphyrins after exposure to 5-aminolevulinic acid (5-ALA). The present experiments have been designed to elucidate whether the C6 glioma cell, a model cell for human malignant glioma, similarly synthesizes porphyrins when exposed to 5-ALA, and whether specific synthesis occurs when C6 cells are inoculated into rat brains to form a tumor. In this situation the blood-brain barrier may interfere with 5-ALA availability, and spreading of porphyrins with edema outside the tumor may occur. Flow cytometry is used to determine the course of cell volume and porphyrin fluorescence intensities in cultured C6 cells which are incubated in 1 mM 5-ALA. For the induction of experimental brain tumors, 10(4) untreated C6 cells are inoculated into the brains of rats. After 9 days animals receive 100 mg 5-ALA/kg body weight. Brains are removed after 3, 6, or 9 h and frozen coronal sections obtained for H/E staining or fluorescence spectography. Cultured C6 cells show a linear increase of protoporphyrin IX fluorescence after exposure to 5-ALA, which begins to plateau after 85 min. Marked fluorescence is also observed in solid and infiltrating experimental tumor. However, faint fluorescence also occurs in normal tissue, basal pia, choroid plexus, and, more obviously, in white-matter tracts bordering the tumor (maximal distance: 1.5 +/- 0.7 mm). The observations demonstrate that C6 cells synthesize protoporphyrin IX after exposure to 5-ALA in vitro and in vivo. However, when utilizing 5-ALA for fluorescence detection or photodynamic therapy of brain tumors, attention should be paid to the possibility of protoporphyrin IX occurring outside the tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9868806     DOI: 10.1016/s1011-1344(98)00176-6

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  53 in total

1.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids.

Authors:  Steen J Madsen; Chung-Ho Sun; Bruce J Tromberg; Henry Hirschberg
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

Review 2.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 3.  The impact of cerebral metastases growth pattern on neurosurgical treatment.

Authors:  Marcel A Kamp; Philipp J Slotty; Jan F Cornelius; Hans-Jakob Steiger; Marion Rapp; Michael Sabel
Journal:  Neurosurg Rev       Date:  2016-07-09       Impact factor: 3.042

Review 4.  Fluorescein-guided surgery for malignant gliomas: a review.

Authors:  Francesco Acerbi; Claudio Cavallo; Morgan Broggi; Roberto Cordella; Elena Anghileri; Marica Eoli; Marco Schiariti; Giovanni Broggi; Paolo Ferroli
Journal:  Neurosurg Rev       Date:  2014-04-23       Impact factor: 3.042

5.  5-ALA fluorescence behavior of cerebral infectious and inflammatory disease.

Authors:  Julia Steinmann; Marion Rapp; Bernd Turowski; Hans-Jakob Steiger; Jan Frederick Cornelius; Michael Sabel; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2017-06-07       Impact factor: 3.042

Review 6.  Fluorescence-guided surgery with aminolevulinic acid for low-grade gliomas.

Authors:  Benjamin K Hendricks; Nader Sanai; Walter Stummer
Journal:  J Neurooncol       Date:  2018-10-26       Impact factor: 4.130

7.  Quantification of ALA-fluorescence induced by a modified commercially available head lamp and a surgical microscope.

Authors:  Michael Sabel; Johannes Knipps; Lisa Margarete Neumann; Max Kieslich; Hans-Jakob Steiger; Marion Rapp; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2018-07-23       Impact factor: 3.042

8.  Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.

Authors:  J Scott Cordova; Saumya S Gurbani; Chad A Holder; Jeffrey J Olson; Eduard Schreibmann; Ran Shi; Ying Guo; Hui-Kuo G Shu; Hyunsuk Shim; Costas G Hadjipanayis
Journal:  Mol Imaging Biol       Date:  2016-06       Impact factor: 3.488

9.  Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials.

Authors:  James S Cordova; Eduard Schreibmann; Costas G Hadjipanayis; Ying Guo; Hui-Kuo G Shu; Hyunsuk Shim; Chad A Holder
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

10.  Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.

Authors:  Shawn Hingtgen; Jose-Luiz Figueiredo; Christian Farrar; Matthias Duebgen; Jordi Martinez-Quintanilla; Deepak Bhere; Khalid Shah
Journal:  J Neurooncol       Date:  2012-12-16       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.